First AD

Dr Wakelee to Dr Sands: For clinicians who may not have access to “in-house” molecular testing at their institutional or community site and have to outsource these tests, are there any potential strategies to employ to ensure an appropriate turnaround time?
Dr Sands to Dr Wakelee: At your institution, how long does it typically take to receive the results for biomarker testing?

Second AD

Practical Considerations in Metastatic NSCLC: Access and Timing of Testing

 For clinicians who may not have access to “in-house” molecular testing at their institutional or community site and have to outsource these tests, are there any potential strategies to employ to ensure an appropriate turnaround time?

At your institution, how long does it typically take to receive the results for biomarker testing?

Video Series

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

My Treatment Approach: My Treatment Approach: Navigating Genetic Testing and RET-Targeted Treatments in NSCLC 

Panelists discuss strategies for clinicians without access to in-house molecular testing, focusing on how to ensure appropriate turnaround times when outsourcing tests and share insights on the typical timeline for receiving biomarker testing results at their respective institutions.